DK1421946T3 - Et farmaceutisk præparat til behandling af HIV-infektion - Google Patents

Et farmaceutisk præparat til behandling af HIV-infektion

Info

Publication number
DK1421946T3
DK1421946T3 DK02742656T DK02742656T DK1421946T3 DK 1421946 T3 DK1421946 T3 DK 1421946T3 DK 02742656 T DK02742656 T DK 02742656T DK 02742656 T DK02742656 T DK 02742656T DK 1421946 T3 DK1421946 T3 DK 1421946T3
Authority
DK
Denmark
Prior art keywords
group
hiv infection
treatment
pharmaceutical composition
amino
Prior art date
Application number
DK02742656T
Other languages
Danish (da)
English (en)
Inventor
Genfa Zhou
Wangni Tian
Original Assignee
Tianjin Fusogen Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Fusogen Biotech Co Ltd filed Critical Tianjin Fusogen Biotech Co Ltd
Application granted granted Critical
Publication of DK1421946T3 publication Critical patent/DK1421946T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK02742656T 2001-08-29 2002-06-06 Et farmaceutisk præparat til behandling af HIV-infektion DK1421946T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN01130985A CN1100564C (zh) 2001-08-29 2001-08-29 用于治疗hiv感染的药物、其组合物及其用途
PCT/CN2002/000405 WO2003018045A1 (fr) 2001-08-29 2002-06-06 Medicament a utiliser pour le traitement des infections a vih, composition et utilisations correspondantes

Publications (1)

Publication Number Publication Date
DK1421946T3 true DK1421946T3 (da) 2008-12-01

Family

ID=4670295

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02742656T DK1421946T3 (da) 2001-08-29 2002-06-06 Et farmaceutisk præparat til behandling af HIV-infektion

Country Status (9)

Country Link
US (2) US6962900B2 (fr)
EP (1) EP1421946B1 (fr)
JP (1) JP2004538334A (fr)
CN (1) CN1100564C (fr)
AT (1) ATE404215T1 (fr)
DE (1) DE60228269D1 (fr)
DK (1) DK1421946T3 (fr)
RU (1) RU2290197C2 (fr)
WO (1) WO2003018045A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1100564C (zh) * 2001-08-29 2003-02-05 周根发 用于治疗hiv感染的药物、其组合物及其用途
JP2007517522A (ja) * 2004-01-07 2007-07-05 トリメリス，インコーポレーテッド ＨＩＶｇｐ４１ＨＲ２由来の合成ペプチド、およびヒト免疫不全ウイルスの伝播を阻止する治療におけるその使用
EP1989220B1 (fr) 2006-02-02 2011-12-14 Trimeris, Inc. Peptides inhibiteurs de fusion du vih à propriétés biologiques améliorées
US7662547B2 (en) * 2006-05-05 2010-02-16 George Mason Intellectual Properties, Inc. Compositions and methods for detecting and treating HIV infections
CN101088557A (zh) 2006-06-12 2007-12-19 天津市扶素生物技术有限公司 用于预防或治疗hiv感染的药用组合物及其应用
BRPI0809995A2 (pt) * 2007-04-03 2015-07-21 Trimeris Inc Composição, e, métodos para a liberação prolongada de um peptídeo em um paciente e para melhorar um sintoma associado com uma infecção por hiv
BRPI0817697A2 (pt) * 2007-09-25 2015-04-07 Trimeris Inc Método de síntese de um peptídeo, conjunto de fragmentos de peptídeo, e, peptídeo
US20100021427A1 (en) * 2008-05-29 2010-01-28 Tianjin Fusogen Pharmaceuticals, Inc. Use of Antiviral Peptides For Treatment of Infections Caused by Drug-Resistant HIV
EP2603241A2 (fr) 2010-08-11 2013-06-19 Jv Bio Srl Inhibiteurs multimères de fusion virale et ses utilisations
CN102180951B (zh) * 2011-05-03 2012-09-26 中国医学科学院病原生物学研究所 胆固醇修饰的抗hiv多肽药物及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004374A1 (fr) * 1990-09-11 1992-03-19 Seikagaku Kogyo Co., Ltd. Nouveau polypeptide et medicament anti-vih prepare a partir de ce polypeptide
HUT61036A (en) * 1991-05-02 1992-11-30 Seikagaku Kogyo Co Ltd Process for producing new polypeptides capable of linking to lipopolysaccharides and pharmaceutical compositions comprising same as active ingredients
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
AU688733B2 (en) * 1992-07-20 1998-03-19 Duke University Compounds which inhibit HIV replication
DE69426725T2 (de) * 1993-09-11 2001-09-06 Polimun Scientific Immunbiologische Forschungsgesellschaft Mbh, Wien Peptide, die neutralisierende antikörper gegen genetisch divergierende hiv-1 stämme, induzieren
IL110929A0 (en) * 1993-09-13 1994-11-28 Armel Sa Multiple branch peptide constructions and pharmaceutical compositions containing them
CZ287239B6 (en) * 1993-10-14 2000-10-11 Seikagaku Kogyo Co Ltd Polypeptides exhibiting antimicrobial and antiviral activity and pharmaceutical preparations containing thereof
RU2137768C1 (ru) * 1993-12-15 1999-09-20 Мерк энд Ко, Инк. Ингибиторы hiv протеазы
US6258782B1 (en) * 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
WO1999062945A2 (fr) * 1998-06-05 1999-12-09 Peptide Solutions, Inc. Peptides universels
JP5101764B2 (ja) * 1998-07-30 2012-12-19 ホワイトヘッド インスチチュート フォアー バイオメディカル リサーチ Ｈｉｖ膜融合のインヒビター
CN1100564C (zh) * 2001-08-29 2003-02-05 周根发 用于治疗hiv感染的药物、其组合物及其用途

Also Published As

Publication number Publication date
US20060100139A1 (en) 2006-05-11
HK1067531A1 (en) 2005-04-15
US6962900B2 (en) 2005-11-08
US7335727B2 (en) 2008-02-26
US20040248789A1 (en) 2004-12-09
EP1421946B1 (fr) 2008-08-13
CN1334122A (zh) 2002-02-06
WO2003018045A1 (fr) 2003-03-06
RU2004108858A (ru) 2005-05-10
EP1421946A1 (fr) 2004-05-26
ATE404215T1 (de) 2008-08-15
EP1421946A4 (fr) 2005-08-31
CN1100564C (zh) 2003-02-05
RU2290197C2 (ru) 2006-12-27
JP2004538334A (ja) 2004-12-24
DE60228269D1 (de) 2008-09-25

Similar Documents

Publication Publication Date Title
BR0207809A (pt) Compostos heteroarila contendo nitrogênio possuindo atividade inibidora contra integrase de hiv
NL300283I1 (nl) Alfa- en bèta-aminozuur-hydroxyethylamino-sulfonamiden die toepasbaar zijn als retrovirale-prothease-remmers.
AU3413100A (en) Method and compositions for preventing or reducing hiv infection by use of inhibitors for leucine aminopeptidase
BR0308081A (pt) Inibidores de histona desacetilase
AU667146B2 (en) Inhibitors of HIV protease useful for the treatment of AIDS
GB2431404A (en) Peptide
FI942423A0 (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
EA199700221A1 (ru) Замещенный аминокислотой гидроксиэтиламиносульфонамид в качестве ингибиторов ретровирусной протеазы
NO974147D0 (no) Heterocykelkarbonyl aminosyre hydroksyetylamino sulfonamid retroviral protease
ATE368645T1 (de) Aminosäurederivate als hiv-protease-inhibitoren
BR0209695A (pt) Conjugados de lipìdeo-polìmero
DE60228269D1 (de) Pharmazeutische zusammensetzung zur behandlung einer hiv-infektion
DK0604183T3 (da) HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
FI962488A0 (fi) HIV:n proteaasin inhibiittoreita
DK1053012T3 (da) Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner
DK0604186T3 (da) HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
HK1041444A1 (zh) 用於治療hiv感染的包含peg-天冬酰胺酶的藥物組合物
GB2379388A (en) Use of metal compounds to treat gastrointestinal infections
ATE491709T1 (de) Pyrrolidinohydrochinazoline
WO1998023574A8 (fr) Derives d'acide asiatique et medicaments les contenant aux fins du traitement de plaies
EE9900188A (et) HIV proteaasi inhibiitoritena kasulikud 1-(3-aminoindasool-5-üül)-3-fenüülmetüül-tsüklilised uuread
IT1318424B1 (it) Composti con attivita' anti-hiv.
WO2002002087A3 (fr) Produits anthelminthiques permettant de prevenir les infections parasitaires chez l'homme et l'animal ii
WO2002006190A3 (fr) Formes cristallines et salines d'un inhibiteur de protease du vih
EP1176193A4 (fr) Inhibiteurs utilises dans le ciblage d'infections virales d'une region a extremite terminale n de l'integrase